Combined aspirin and clopidogrel in cataract surgical patients: a new risk factor for ocular haemorrhage?

@article{Davies2004CombinedAA,
  title={Combined aspirin and clopidogrel in cataract surgical patients: a new risk factor for ocular haemorrhage?},
  author={Belinda R. Davies},
  journal={The British journal of ophthalmology},
  year={2004},
  volume={88 9},
  pages={
          1226-7
        }
}
Clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi) is a thienopyridine with antiplatelet effects caused by its inhibition of ADP mediated platelet aggregation pathways.1 Both aspirin and clopidogrel have established benefits in the secondary prevention of fatal and non-fatal coronary and cerebrovascular events.1,2 The CURE study has concluded that combining low dose aspirin and clopidogrel in patients with acute coronary syndromes results in additional improvements in outcome over aspirin alone… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Perioperative management of antiplatelet therapy in patients with drug-eluting stents

  • HSR proceedings in intensive care & cardiovascular anesthesia
  • 2012
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…